Segmentation by type classifies Functional Blood Tests Systems into enzyme assays, hormone panels, metabolite profiling, genetic marker tests, and immunoassays. Enzyme assays measure catalytic activity of specific proteins and are critical for metabolic disorder diagnosis, forming a core component of the clinical diagnostics share. Hormone panels, such as thyroid or reproductive hormone profiles, support both diagnostic and preventive applications, especially in endocrinology and women's health, adding a moderate proportion to overall sales. Metabolite profiling, which quantifies small molecules like amino acids or lipids, underpins personalized nutrition and chronic disease monitoring, expanding the preventive health segment. Genetic marker tests detect DNA variations linked to disease susceptibility or drug response, primarily used in research and increasingly in precision‑medicine diagnostics, thereby influencing higher‑margin market pockets. Immunoassays, employing antibody‑based detection, remain the most versatile format across all applications, contributing the largest slice of the type‑based market due to their broad clinical utility.